Matthew K. Szot - Jan 18, 2024 Form 4 Insider Report for Cadrenal Therapeutics, Inc. (CVKD)

Role
Chief Financial Officer
Signature
/s/ Matthew K. Szot
Stock symbol
CVKD
Transactions as of
Jan 18, 2024
Transactions value $
$0
Form type
4
Date filed
1/19/2024, 07:39 PM
Previous filing
Jun 29, 2023
Next filing
Aug 28, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVKD Stock Options Award $0 +250K $0.00 250K Jan 18, 2024 Common Stock 250K $0.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months.